Awarding a European prize is equivalent to a validation of the Technology readiness level (TRL) of the project by an independent body (European commission: Executive Agency for Small and Medium-sized Enterprises – EASME).

2017 H2020 SME INSTRUMENT phase-2 Topic :SMEInst-03-2017. European commission


2015 H2020 SME INSTRUMENT phase-1 Topic : BIOTEC-5a2015. European commission


2015 17th i-Lab “Créadev” BPI France


2013 15th “émergence” OSEO/BPI


2013 – Innovation Days One of 15 finalists “Innovation Prize” Universal Biotech.

Contact Info

Parc scientifique Biocitech
102 Avenue Gaston Roussel
Batiment Pasteur Secteur 2169
93230 Romainville - France

56 Boulevard de la Mission Marchand - 92400 Courbevoie France

Phone: +33 1 43 34 89 90

Mobile: +33 6 60 90 41 24

2018 – Partnership between REGULAXIS and ARTIALIS

REG-O3, the innovative therapeutic treatment for Osteoarthritis will be tested in Liège !:
Artialis, specialist in the study of the musculoskeletal disorders and Regulaxis, an innovative French company in the treatment of osteoarthritis, announce today the signing of a 1.6 million euros contract for the preclinical and clinical development of a new molecule, Reg-O3, allowing […]

June 15th, 2018|0 Comments

2018 – Liverpool – OARSI World Congress on Osteoarthritis

REGULAXIS, a leader in peptide research and development, will presents its most recent preclinical data of REG-O3, an innovative chimeric peptide for the treatment of osteoarthritis of knee at the 2018 Osteoarthritis Research Society International World Congress (OARSI), to be held April 26-29, 2018 in Liverpool, UK.

April 26th, 2018|0 Comments

2018 – Macau, China – 14th World Congress of ICRS

Regulaxis is proud to present the recent results on the effectiveness of REG-O3 in a model of traumatic knee osteoarthitis.
“REG-O3, new chimeric peptides regulating IGF-1 pathway: significant therapeutic effect on ACLT rabbit model of osteoarthritis”
Raffaello PAOLINI, Rodrick MONTJEAN and Christelle VETU

April 9th, 2018|0 Comments


Regulaxis is proud to announce to receive € 2.1m from EU Horizon 2020 SME instrument Phase 2 program for early gonarthrosis (OA) therapeutic drug regenerating cartilage !

May 1st, 2017|0 Comments

2016 – Romainville, France – BIOCITECHDAY

Dr. Claude Carelli, President and CEO of REGULAXIS, presented to BIOCITECHDAY the innovative molecule under development for the therapeutic treatment of knee osteoarthritis.

June 28th, 2016|0 Comments

2015 – Paris, France – I-LAB 2015


Drs Christelle Vêtu and Claude Carelli are proud to announce that REGULAXIS has been awarded at the 17th National Contest for the Creation of Innovative Enterprises organized by the Ministry of Higher Education, Research and Innovation. The prize consists of a grant of € 200k.

July 1st, 2015|0 Comments

2014 – Regulaxis in the French Magazine “Challenges”

Regulaxis SAS is proud to announce that it has been selected by the economy newspaper Challenge in its issue of 17-23 April 2014 for the 2014 edition of its record of 100 French start-ups in which it is advisable to invest.

April 18th, 2014|0 Comments

2013 – Paris, France – REGULAXIS at The Universal Biotech Innovation Prize

The Universal Biotech Innovation Prize is open to Small and Medium Enterprises from Europe and China and to academics researchers on preventive and curative therapies, medical devices, technological tools.
Regulaxis project finished 15th on 81 companies  from 16 european countries at the the Universal Biotech Innovation Prize.

October 7th, 2013|0 Comments

2013 – Bobigny, France – REGULAXIS SAS is officially incorporated as a French company based in BIOCITECH, Romainville, France.

Regulaxis is officially incorporated as a French company based at Biocitech life science park and hire its first employee.

September 11th, 2013|0 Comments

2013 – REGULAXIS awarded in emergeance category at the French Research Minister “Concours national”

Regulaxis won a prize of the “15eme concours national d’aide à la création d’entreprises de technologies innovantes” organize by the French Research Ministery in emergeance category.
The money prize is 20.000€ and participate to the launch of the company.
On the 175 winners this year only 3 were coming from biotech companies proposing the development of […]

July 2nd, 2013|0 Comments